Okay, let me tackle this question about the drug used for closing a patent ductus arteriosus. First, I need to recall what PDA is. It's a congenital heart defect where the ductus arteriosus doesn't close after birth. Normally, the ductus closes shortly after birth, but in some cases, it stays open.

The question is about the drug used for closure. I remember that in neonates, especially preterm infants, medical management is often tried before surgery. The drugs used are usually nonsteroidal anti-inflammatory drugs (NSAIDs) like indomethacin or ibuprofen. These drugs work by inhibiting prostaglandin synthesis. Prostaglandins, particularly PGE2, are responsible for keeping the ductus open. So inhibiting their production causes the ductus to constrict and close.

Looking at the options, if the correct answer is ibuprofen, then the other options might be other drugs that don't act on prostaglandins. Let's think about the other options. If an option is an ACE inhibitor, that's used for hypertension, not PDA. Beta-blockers might be used in other contexts, like hypertension or arrhythmias. Diuretics could be used for heart failure, but not for closing a PDA. A drug like aminophylline is a bronchodilator and wouldn't affect the ductus. So the correct answer should be an NSAID, either indomethacin or ibuprofen. Both are used, but ibuprofen is sometimes preferred due to fewer side effects.

So the core concept here is the role of prostaglandins in maintaining the patency of the ductus arteriosus and how NSAIDs inhibit their synthesis. The correct answer would be ibuprofen or indomethacin. The other options are incorrect because they don't target prostaglandin pathways. The clinical pearl is that NSAIDs are first-line for medical closure of PDA in preterm infants.

**Core Concept**
Patent ductus arteriosus (PDA) is a congenital heart defect where the ductus arteriosus remains open postnatally. Closure is mediated by inhibiting prostaglandin synthesis, as prostaglandin E2 (PGE2) maintains ductal patency via smooth muscle relaxation.

**Why the Correct Answer is Right**
Ibuprofen, a nonsteroidal anti-inflammatory drug (NSAID), inhibits cyclooxygenase (COX) enzymes, reducing PGE2 production. This promotes ductus constriction by enhancing vasoconstrictive prostaglandins (e.g., PGF2α) and decreasing vasodilatory PGE2. It is preferred in preterm infants due to fewer nephrotoxic effects compared to indomethacin.

**Why Each Wrong Option is Incorrect**
**Option A:** Aminophylline is a bronchodilator with no role in PDA closure.
**Option B:** Furosemide is a diuretic; it reduces fluid overload but does not affect ductal patency.
**Option C:** Dopamine is a vasopressor used for hypotension, not PDA closure.

**Clinical Pearl / High-Yield Fact**
NSAIDs (ibuprofen/indomethacin) are first-line for medical PDA closure

✓ Correct Answer: C. Indomethacin